Elicio Therapeutics, Inc. (ELTX)
Nasdaq: ELTX · CIK 0001601485 · United States
Every official Elicio Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ELTX filings
Elicio Therapeutics, Inc. documents
- Elicio Therapeutics, Inc. 10-K 2026ELTX 10-K 2026: annual report for fiscal 2026
- Elicio Therapeutics, Inc. 10-K 2025ELTX 10-K 2025: annual report for fiscal 2025
- Elicio Therapeutics, Inc. 10-K 2024ELTX 10-K 2024: annual report for fiscal 2024
- Elicio Therapeutics, Inc. 10-K 2023ELTX 10-K 2023: annual report for fiscal 2023
- Elicio Therapeutics, Inc. 10-K 2022ELTX 10-K 2022: annual report for fiscal 2022
- Elicio Therapeutics, Inc. 10-Q 2026ELTX 10-Q 2026: quarterly report for fiscal 2026
- Elicio Therapeutics, Inc. 10-Q 2025ELTX 10-Q 2025: quarterly report for fiscal 2025
- Elicio Therapeutics, Inc. 10-Q 2024ELTX 10-Q 2024: quarterly report for fiscal 2024
- Elicio Therapeutics, Inc. 10-Q 2023ELTX 10-Q 2023: quarterly report for fiscal 2023
- Elicio Therapeutics, Inc. 10-Q 2022ELTX 10-Q 2022: quarterly report for fiscal 2022
- Elicio Therapeutics, Inc. 8-K 2026ELTX 8-K 2026: current report for fiscal 2026
- Elicio Therapeutics, Inc. 8-K 2025ELTX 8-K 2025: current report for fiscal 2025
- Elicio Therapeutics, Inc. 8-K 2024ELTX 8-K 2024: current report for fiscal 2024
- Elicio Therapeutics, Inc. 8-K 2023ELTX 8-K 2023: current report for fiscal 2023
- Elicio Therapeutics, Inc. 8-K 2022ELTX 8-K 2022: current report for fiscal 2022
- Elicio Therapeutics, Inc. DEF 14A 2026ELTX DEF 14A 2026: proxy statement for fiscal 2026
- Elicio Therapeutics, Inc. DEF 14A 2025ELTX DEF 14A 2025: proxy statement for fiscal 2025
- Elicio Therapeutics, Inc. DEF 14A 2024ELTX DEF 14A 2024: proxy statement for fiscal 2024
- Elicio Therapeutics, Inc. DEF 14A 2023ELTX DEF 14A 2023: proxy statement for fiscal 2023
- Elicio Therapeutics, Inc. DEF 14A 2022ELTX DEF 14A 2022: proxy statement for fiscal 2022
- Elicio Therapeutics, Inc. Form 4 2026ELTX Form 4 2026: insider trading filing for fiscal 2026
- Elicio Therapeutics, Inc. Form 4 2025ELTX Form 4 2025: insider trading filing for fiscal 2025
- Elicio Therapeutics, Inc. Form 4 2024ELTX Form 4 2024: insider trading filing for fiscal 2024
- Elicio Therapeutics, Inc. Form 4 2023ELTX Form 4 2023: insider trading filing for fiscal 2023
- Elicio Therapeutics, Inc. Form 4 2022ELTX Form 4 2022: insider trading filing for fiscal 2022
- Elicio Therapeutics, Inc. S-1 2026ELTX S-1 2026: registration statement for fiscal 2026
- Elicio Therapeutics, Inc. S-1 2025ELTX S-1 2025: registration statement for fiscal 2025
- Elicio Therapeutics, Inc. S-1 2024ELTX S-1 2024: registration statement for fiscal 2024
- Elicio Therapeutics, Inc. S-1 2023ELTX S-1 2023: registration statement for fiscal 2023
- Elicio Therapeutics, Inc. S-1 2022ELTX S-1 2022: registration statement for fiscal 2022
- Elicio Therapeutics, Inc. 13F 2026ELTX 13F 2026: institutional holdings for fiscal 2026
- Elicio Therapeutics, Inc. 13F 2025ELTX 13F 2025: institutional holdings for fiscal 2025
- Elicio Therapeutics, Inc. 13F 2024ELTX 13F 2024: institutional holdings for fiscal 2024
- Elicio Therapeutics, Inc. 13F 2023ELTX 13F 2023: institutional holdings for fiscal 2023
- Elicio Therapeutics, Inc. 13F 2022ELTX 13F 2022: institutional holdings for fiscal 2022
More companies